| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2005 | US20050049261 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 03/03/2005 | US20050049260 2-phenyl-4-pyridinyl- or -pyrimidinyl derivatives, e.g., N-Cyclopentyl-3-[2-(cyclopentylamino)-4-pyrimidinyl]-2-(4-methoxyphenyl)-pyrazolo[1,5-a]pyridin-7-amine and; especially for treatment of herpes simplex virus 1 and 2 |
| 03/03/2005 | US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections |
| 03/03/2005 | US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 03/03/2005 | US20050049256 Treatment of inflammatory autoimmune diseases with alpha-adrenergic antagonists and beta-adrenergic agonists |
| 03/03/2005 | US20050049255 Synergistic combination of vasopressin receptor antagonist and phosphodiesterase inhibitor; dysmenorrhoea |
| 03/03/2005 | US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 03/03/2005 | US20050049251 Inhibitors of p38 |
| 03/03/2005 | US20050049250 7-Aikyl and cycloalkyl-substituted imidazotriazinones |
| 03/03/2005 | US20050049249 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 03/03/2005 | US20050049248 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility; cancer, rheumatoid arthritis, stroke, cardiovascular inflammation |
| 03/03/2005 | US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine |
| 03/03/2005 | US20050049244 osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis |
| 03/03/2005 | US20050049243 Acetylcholinesterase (AChE), metabotropic glutamate receptor 2 (mGluR2); alzheimer's disease, cognitive impairment |
| 03/03/2005 | US20050049242 Synergistic combination with reverse transcriptase and/or a protease inhibitors |
| 03/03/2005 | US20050049241 Vanilloid receptor antagonists; acute or chronic pain, itching; inflammation; gastrointestinal and urinary tract disorders; tracheobronchial and diaphragmatic dysfunction |
| 03/03/2005 | US20050049240 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 03/03/2005 | US20050049238 Heterocyclic retinoid compounds |
| 03/03/2005 | US20050049237 Pyrazole-amides and -sulfonamides |
| 03/03/2005 | US20050049236 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 03/03/2005 | US20050049235 Amino ceramide-like compounds and therapeutic methods of use |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/03/2005 | US20050049232 Preventing hair loss and/or stimulating growth; active ingredient combined with lipophilic and hydrophilic two phase system; creates semipermeable membrane in skin holding medication in appropriate area; reduced irritation and systemic effects |
| 03/03/2005 | US20050049231 Local delivery of aromatase inhibitor using intravaginal device; estrogen dependent proliferative disorders of uterus; minimal side effects, longer term treatment, variable dosage |
| 03/03/2005 | US20050049229 Antiinflammatory and/or antiplatelet aggregation actions; lower toxicity, reducing liver and/or kidney damage; analgesic and antipyretic activity |
| 03/03/2005 | US20050049227 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 03/03/2005 | US20050049225 Use of bisphosphonates for otosclerosis |
| 03/03/2005 | US20050049224 Antimicrobial mixtures comprising iodopropynyl compounds and dimethyldithiocarbamate derivatives |
| 03/03/2005 | US20050049220 Dosing regimen for Flaviviridae therapy |
| 03/03/2005 | US20050049216 Immunostimulatory nucleic acid molecules |
| 03/03/2005 | US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex |
| 03/03/2005 | US20050049213 Method for preventing or reversing asthma and compositions useful therefor |
| 03/03/2005 | US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides |
| 03/03/2005 | US20050049211 Oligonucleotides for treating hyperproliferative diseases such as cancer, inflammatory, developmental or metabolic disorders |
| 03/03/2005 | US20050049210 Methods for the controlled delivery of pharmacologically active compounds |
| 03/03/2005 | US20050049209 Pharmaceutical compositions for delivering macrolides |
| 03/03/2005 | US20050049208 Administering antifungal agents; combination with a low carbohydrate diet; antifungal agents such as fluconazole, nystatin, itraconazole, terbinafine, ketoconazole, clotrimazole, caspofungin, voriconazole, amphotericin B, flucytosine, and griseofulvin |
| 03/03/2005 | US20050049207 Method of treating and preventing cancer |
| 03/03/2005 | US20050049206 Compositions of flavonoids and flavonoid-containing extracts and the treatment of diseases |
| 03/03/2005 | US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis |
| 03/03/2005 | US20050049204 Compounds for the treatment of flaviviridae infections |
| 03/03/2005 | US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides |
| 03/03/2005 | US20050049195 Methods and compositions for nerve regeneration |
| 03/03/2005 | US20050049182 Therapeutic formulation comprising cationic peptide, viscosity-increasing agent, and solvent, wherein the cationic peptide contains up to 35 amino acids; use in treating or preventing infectious disease associated with foreign bodies, primary or seconary infection sites |
| 03/03/2005 | US20050049174 Reducing the severity of hemodynamic instability in a subject undergoing cardiac surgery involving an extra-corporal circulation by administration through inhalation of a therapeutically effective amount of a vasodilatator to the subject |
| 03/03/2005 | US20050048641 System and method for delivering polynucleotides to the central nervous system |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof |
| 03/03/2005 | US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides |
| 03/03/2005 | US20050048476 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 03/03/2005 | US20050048460 Using abrutin to stabilze blood platelets and cell mixtures |
| 03/03/2005 | US20050048149 Controlling weight, obesity; antidiabetic agents; using apple juice extract |
| 03/03/2005 | US20050048148 Synergistic mixtures; balancing (pro/anti)inflammatory cytokines |
| 03/03/2005 | US20050048143 Antioxidant compositions and methods thereto |
| 03/03/2005 | US20050048140 Topical compositions having a natural ingredient and method of use |
| 03/03/2005 | US20050048136 Rehydrating beverage with Rhodiola crenulata and D-ribose that enhances blood oxygen and relieves post-exertional muscle cramping and soreness |
| 03/03/2005 | US20050048135 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 03/03/2005 | US20050048128 Using ascorbic acid and petroleum jelly |
| 03/03/2005 | US20050048126 Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| 03/03/2005 | US20050048125 Glycoprotein matrix compositions and methods related thereto |
| 03/03/2005 | US20050048124 Antimicrobial composition for medical articles |
| 03/03/2005 | US20050048123 Liquid sustained release ; in situ injecting of water insoluble gel in polyoxyethylene glycol solvent |
| 03/03/2005 | US20050048122 Method for stabalizing timolol concentration |
| 03/03/2005 | US20050048119 Core containing antihypoglycemic agent with water soluble seal coating and semipermeable membrane |
| 03/03/2005 | US20050048118 Core containing lipophilic matric with drug; protective coatings |
| 03/03/2005 | US20050048117 Therapy for opioid induced side effects; gastrointestinal disorders |
| 03/03/2005 | US20050048115 Buprenorphine microspheres |
| 03/03/2005 | US20050048114 Antibiotic product, use and formulation thereof |
| 03/03/2005 | US20050048113 In situ administering of antisecretory agents and antacid |
| 03/03/2005 | US20050048112 Solid pharmaceutical dosage form |
| 03/03/2005 | US20050048107 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml |
| 03/03/2005 | US20050048106 Administering as a transdermal patch comprising oxybutynin to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1 with a peak oxybutynin metabolite plasma concentration of less than about 8 ng/ml |
| 03/03/2005 | US20050048105 Forming skin barrier; polymer mixture containing protease inhibitor |
| 03/03/2005 | US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 03/03/2005 | US20050048101 Plaster for topical use containing heparin and diclofenac |
| 03/03/2005 | US20050048098 Semirigid eye implant; glycolic acid-lactic acid copolymer and release moderator for dexamethasome; |
| 03/03/2005 | US20050048093 Methods and reagents for the control of infestations of parasites |
| 03/03/2005 | US20050048086 Oral administering; gastric retension; drug delivery |
| 03/03/2005 | US20050048085 Exposure of infant mammal or bird to radiation detoxification lipopolysaccharide devived from microbial, fung al, protozoa endotoxin |
| 03/03/2005 | US20050048072 Topical administering mixtuure of immune response moderator and another drug |
| 03/03/2005 | US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/03/2005 | US20050048043 Methods for in vivo gene transfer into pancreatic and biliary epithelial cells |
| 03/03/2005 | US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 03/03/2005 | US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/03/2005 | US20050048026 Remedies for ischemic diseases |
| 03/03/2005 | US20050048024 Compounds for use as surfactants |
| 03/03/2005 | US20050048012 Use of biotin or a biotin derivative for skin lightening purposes and for the treatment of senile lentigines |
| 03/03/2005 | US20050048011 Skin preparation comprising a tocopherol derivative for external application |
| 03/03/2005 | US20050048001 Aerosol form; dissolved in fluorohydrocarbon; canister containing valve; inhalation therapy |
| 03/03/2005 | DE10337368A1 Diagnosis of pancreatic cancer by detecting expression of the a disintegrin and metalloprotease domain 9 (ADAM9) protein using specific antibodies, also therapeutic use of these antibodies and of ADAM9-specific nucleic acids |
| 03/03/2005 | DE10335634A1 Antimikrobielle Wirkstoffe Antimicrobial Agents |
| 03/03/2005 | DE10334188A1 Verwendung von Rotigotin zur Behandlung von Depressionen Use of rotigotine for treatment of depression |
| 03/03/2005 | DE10334187A1 Substituierte 2-Aminotetraline zur Behandlung von Depressionen Substituted 2-aminotetralines for the treatment of depression |
| 03/03/2005 | DE102004028415A1 Dermales oder transdermales therapeutisches System enthaltend eine Abdeckfolie mit Barrierewirkung The dermal or transdermal therapeutic system comprising a cover sheet with barrier effect |
| 03/03/2005 | CA2816222A1 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2005 | CA2776692A1 Penetrating pharmaceutical foam |
| 03/03/2005 | CA2644316A1 Crystal of 1-methyl carbapenem compound |
| 03/03/2005 | CA2551075A1 Immunostimulatory combinations and treatments |
| 03/03/2005 | CA2537257A1 Fexofenadine polymorphs and processes of preparing the same |